Recurrent Hepatitis in Two Iranian Children: A Novel (Q166R) Mutation in EIF2AK3 Leading to Wolcott-Rallison Syndrome

被引:5
作者
Behnam, Babak [1 ,2 ,3 ]
Shakiba, Marjan [4 ]
Ahani, Ali [5 ]
Azar, Maryam Razzaghy [3 ,6 ]
机构
[1] Iran Univ Med Sci, Cellular & Mol Res Ctr, Tehran, Iran
[2] Iran Univ Med Sci, Fac Med, Dept Med Genet & Mol Biol, Tehran, Iran
[3] Iran Univ Med Sci, Ali Asghar Children Hosp, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Mofid Hosp, Dept Pediat, Tehran, Iran
[5] Avicenna Res Ctr, Dept Genet & Reprod, Tehran, Iran
[6] Univ Tehran Med Sci, Endocrine & Metab Res Ctr, Tehran, Iran
关键词
Wolcott-Rallison Syndrome; Diabetes Mellitus; Spondyloepiphyseal Dysplasia; GENE;
D O I
10.5812/hepatmon.10124
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Early-onset diabetes, liver dysfunction, growth retardation, spondyloepiphyseal dysplasia, and tendency to skeletal fractures due to osteopenia are characteristics of Wolcott-Rallison syndrome (WRS). Eukaryotic translation initiation factor 2 alpha kinase (EIF2AK3) is the only known gene, which is responsible for this rare autosomal recessive disorder. Here, we report two siblings a girl and a boy with diabetes mellitus (DM) who presented in one and two months of age respectively. Recurrent self-limiting hepatitis developed later, and severe hepatic failure resulted in death of the first child. The second child visited was a 7.75 year old boy who had spondyloepiphyseal dysplasia and subclinical hypothyroidism besides DM and recurrent hepatitis. We suggested WRS for this patient, and it was confirmed by identification of a novel homozygous missense mutation (Q166R) in exon 3 of the EIF2AK3 gene. The aim of this report is to remind the possibility of WRS in isolated neonatal diabetes; while, the other clinical manifestations of this syndrome including its major symptom of recurrent hepatitis may appear later.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 21 条
  • [1] ALGAZALI LI, 1995, CLIN DYSMORPHOL, V4, P227
  • [2] Molecular Intricacies and the Role of ER Stress in Diabetes
    Balasubramanyam, Muthuswamy
    Singh, Lalit P.
    Rangasamy, Sampathkumar
    [J]. EXPERIMENTAL DIABETES RESEARCH, 2012,
  • [3] Loss of kinase activity in a patient with Wolcott-Rallison syndrome caused by a novel mutation in the EIF2AK3 gene
    Biason-Lauber, A
    Lang-Muritano, M
    Vaccaro, T
    Schoenle, EJ
    [J]. DIABETES, 2002, 51 (07) : 2301 - 2305
  • [4] Wolcott-Rallison syndrome: Clinical, radiological and histological findings in a Saudi child
    Bin-Abbas, B
    Shabib, S
    Bo, HN
    Al-Ashwal, A
    [J]. ANNALS OF SAUDI MEDICINE, 2001, 21 (1-2) : 73 - 74
  • [5] Organisation of the human PAX4 gene and its exclusion as a candidate for the Wolcott-Rallison syndrome
    Bonthron, DT
    Dunlop, N
    Barr, DGD
    El Sanousi, AA
    Al-Gazali, LI
    [J]. JOURNAL OF MEDICAL GENETICS, 1998, 35 (04) : 288 - 292
  • [6] Wolcott-Rallison syndrome: pathogenic insights into neonatal diabetes from new mutation and expression studies of EIF2AK3
    Brickwood, S
    Bonthron, DT
    Al-Gazali, LI
    Piper, K
    Hearn, T
    Wilson, DI
    Hanley, NA
    [J]. JOURNAL OF MEDICAL GENETICS, 2003, 40 (09) : 685 - 689
  • [7] Chamoun Z, 2013, BIOL CELL
  • [8] EIF2AK3, encoding translation initiation factor 2-α kinase 3, is mutated in patients with Wolcott-Rallison syndrome
    Delépine, M
    Nicolino, M
    Barrett, T
    Golamaully, M
    Lathrop, GM
    Julier, C
    [J]. NATURE GENETICS, 2000, 25 (04) : 406 - 409
  • [9] INFANCY-ONSET DIABETES-MELLITUS AND MULTIPLE EPIPHYSEAL DYSPLASIA
    DETTMAN, C
    RALLISON, ML
    [J]. JOURNAL OF PEDIATRICS, 1972, 80 (02) : 292 - +
  • [10] Feng Dai-Rong, 2011, Zhonghua Er Ke Za Zhi, V49, P301